Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Ixmyelocel-T (Formerly TRC Autologous Bone Marrow Cells) in Patients With Peripheral Arterial Disease to Treat Critical Limb Ischemia

NCT00468000 is registered in ClinicalTrials.gov with Vericel Corporation as lead sponsor.

NCT NCT00468000
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00468000 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Ixmyelocel-T (Formerly TRC Autologous Bone Marrow Cells) in Patients With Peripheral Arterial Disease to Treat Critical Limb Ischemia
Lead sponsor
Vericel Corporation
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2007
Completion date
March 31, 2011
Enrollment
86 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral arterial disease